Split designed to achieve compliance with Nasdaq minimum bid price requirements BOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics,...
Hence then, the article about transcode therapeutics announces 1 for 28 reverse stock split was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces 1-for-28 Reverse Stock Split )
Also on site :
- Microsoft, Meta, and Google just announced billions more in AI spending. Only Google convinced investors it’s paying off
- Meta’s AI Is Delivering but Comes With a Hefty Price Tag .. PYMNTS.com
- Meryl Streep Turned Down ‘Devil Wears Prada 2’ Before Studio Doubled Her Offer: “I Was Ready To Retire”